Post

SNIPR targets antibiotic resistance with CRISPR-based gene therapy trial

The Danish CRISPR biotech SNIPR BIOME has released the first glimpse at the safety profile for SNIPR001, a gene therapy …

FDA proposes new model for easy-to-understand prescription guides

The US Food and Drug Administration (FDA) has proposed a new model for prescription medication guides for brand name and …

Anocca raises over $36 million for cancer cell therapy studies

Anocca has raised SEK 400 million ($36.7 million) in an equity financing round that will be used to move the …

After US approval, Amylyx faces regulatory hurdle in Europe for ALS treatment

Following a rocky and somewhat controversial road to securing a US Food and Drug Administration (FDA) approval, Amylyx’s amyotrophic lateral …

BBT-401 by Bridge Biotherapeutics for Ulcerative Colitis: Likelihood of Approval

BBT-401 is under clinical development by Bridge Biotherapeutics and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase …